Virus-Like Particles as a Modular System for Novel Vaccines
- 1 January 2002
- journal article
- review article
- Published by S. Karger AG in Intervirology
- Vol. 45 (4-6) , 212-217
- https://doi.org/10.1159/000067912
Abstract
Induction of protective immune responses with recombinant antigens is a major challenge for the vaccine industry. Here we present a molecular assembly system that renders antigens of choice highly repetitive. Using this method, efficient antibody responses may be induced in the absence of adjuvants resulting in protection from viral infection and allergic reactions.Keywords
This publication has 14 references indexed in Scilit:
- A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responsesVaccine, 2002
- Monoclonal antibodies in the clinicNature Biotechnology, 2001
- Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodiesJournal of Clinical Investigation, 2001
- Towards the rational design of Th1 adjuvantsVaccine, 2001
- A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult VolunteersThe Journal of Infectious Diseases, 2001
- NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16Virology, 2001
- Clinical trials of antibody therapyImmunology Today, 2000
- Therapeutic Vaccination with p24-VLP and Zidovudine Augments HIV-Specific Cytotoxic T Lymphocyte Activity in Asymptomatic HIV-Infected IndividualsAIDS Research and Human Retroviruses, 1999
- NEUTRALIZING ANTIVIRAL B CELL RESPONSESAnnual Review of Immunology, 1997
- Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopyCell, 1994